Taux d'incidence de 2012 à 2016, par groupe diagnostique - RNCE

Registre National des Cancers de l’Enfant

Annual number of cases (N), crude, age standardised and cumulative incidence rate of childhood cancer, and sex ratio (mainland France, 2012-2016).

         
           
   

Incidence rate (/million)

 

Diagnostic groups and subgroups

N

Crude

ASR

cumulative

Sex_ratio

I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases

519

44.1

46.1

664.0

1.2

I.a Lymphoid leukemias

413

35.1

36.7

527.9

1.2

I.b Acute myeloid leukemias

75

6.3

6.6

95.7

1.0

I.c Chronic myeloproliferative diseases

10

0.9

0.8

13.5

1.2

I.d Myelodysplastic syndromes and other myeloproliferative diseases

14

1.2

1.3

18.4

1.7

I.e Unspecified and other specified leukemias

6

0.5

0.5

8.0

1.5

II. Lymphomas and reticuloendothelial neoplasms

191

16.2

15.1

241.1

1.9

II.a Hodgkin lymphomas

93

7.9

7.1

118.0

1.3

II.b Non-Hodgkin lymphomas (except Burkitt lymphomas)

56

4.8

4.6

71.4

2.0

II.c Burkitt lymphomas

41

3.5

3.4

51.6

4.0

II.d Miscellaneous lymphoreticular neoplasms

0

0.0

0.0

0.5

-

II.e Unspecified lymphomas

0

0.0

0.0

0.5

-

III. CNS and miscellaneous intracranial and intraspinal neoplasms

480

40.8

41.5

612.7

1.2

III.a Ependymomas and choroid plexus tumors

44

3.8

4.1

57.5

1.3

III.b Astrocytomas

181

15.3

15.9

230.5

1.0

III.c Intracranial and intraspinal embryonal tumors

86

7.3

7.6

110.3

1.5

III.d Other gliomas

62

5.3

5.2

79.3

1.1

III.e Other specified intracranial and intraspinal neoplasms

99

8.4

8.1

126.1

1.2

III.f Unspecified intracranial and intraspinal neoplasms

7

0.6

0.7

9.7

0.9

IV. Neuroblastomas and other peripheral nervous cell tumors

140

11.9

13.8

182.9

1.1

IV.a Neuroblastomas and ganglioneuroblastomas

138

11.7

13.6

180.6

1.1

IV.b Other peripheral nervous cell tumors

2

0.2

0.2

2.8

0.8

V. Retinoblastomas

51

4.4

5.2

67.5

1.1

VI. Renal tumors

95

8.1

9.0

122.3

0.8

VI.a Nephroblastomas and other nonepithelial renal tumors

92

7.8

8.8

119.3

0.8

VI.b Renal carcinomas

3

0.2

0.2

3.5

0.4

VI.c Unspecified malignant renal tumors

0

0.0

0.0

0.0

-

VII. Hepatic tumors

20

1.7

1.9

25.9

1.9

VII.a Hepatoblastomas

17

1.5

1.7

22.4

2.1

VII.b Hepatic carcinomas

3

0.2

0.2

3.3

1.5

VII.c Unspecified malignant hepatic tumors

0

0.0

0.0

0.3

0.0

VIII. Malignant bone tumors

90

7.6

6.9

113.7

1.1

VIII.a Osteosarcomas

40

3.4

3.1

51.2

0.9

VIII.b Chondrosarcomas

2

0.1

0.1

2.3

1.0

VIII.c Ewing tumors and related bone sarcomas

44

3.7

3.4

55.4

1.4

VIII.d Other specified malignant bone tumors

4

0.3

0.3

4.9

1.0

VIII.e Unspecified malignant bone tumors

1

0.1

0.1

1.3

2.9

IX. Soft tissue and other extraosseous sarcomas

110

9.3

9.6

140.3

1.2

IX.a Rhabdomyosarcomas

60

5.1

5.4

76.4

1.3

IX.b Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms

9

0.7

0.8

11.4

0.9

IX.c Kaposi sarcomas

0

0.0

0.0

0.0

-

IX.d Other specified soft tissue sarcomas

33

2.8

2.7

41.5

1.1

IX.e Unspecified soft tissue sarcomas

9

0.7

0.7

11.1

1.2

X. Germ-cell tumors, trophoblastic tumors, and neoplasms of gonads

65

5.5

5.6

83.2

0.9

X.a Intracranial and intraspinal germ cell tumors

27

2.3

2.2

34.3

2.6

X.b Malignant extracranial and extragonadal germ cell tumors

15

1.2

1.5

19.5

0.6

X.c Malignant gonadal germ cell tumors

21

1.8

1.7

27.2

0.4

X.d Gonadal carcinomas

1

0.1

0.1

1.0

0.0

X.e Other and unspecified malignant gonadal tumors

1

0.1

0.1

1.8

0.2

XI. Other malignant epithelial neoplasms and malignant melanomas

72

6.1

5.6

91.5

0.7

XI.a Adrenocortical carcinomas

5

0.5

0.5

7.2

0.9

XI.b Thyroid carcinomas

22

1.9

1.7

27.5

0.5

XI.c Nasopharyngeal carcinomas

4

0.4

0.3

5.5

1.9

XI.d Malignant melanomas

11

0.9

0.9

13.6

0.7

XI.e Skin carcinomas

3

0.3

0.3

4.3

1.1

XI.f Other and unspecified carcinomas

26

2.2

2.0

33.4

0.6

XII. Other and unspecified malignant neoplasms

5

0.5

0.5

7.3

0.8

XII.a Other specified malignant tumors

5

0.4

0.5

6.4

0.7

XII.b Other unspecified malignant tumors

1

0.1

0.1

1.4

1.9

All cancers (excluding Langherhans cell histiocytosis)

1838

156.2

160.8

2349.9

1.2

Langherhans cell histiocytosis

5

0.5

0.6

7.7

1.0

All cancers (including Langherhans cell histiocytosis)

1843

156.6

161.4

2357.6

1.2

           
           
           

Villejuif

INSERM
UMRS1153 Equipe 7
Bâtiment 15/16
16 avenue Paul Vaillant Couturier
94807 Villejuif Cedex

+33 (0)1 45 59 50 37
rnhe@inserm.fr

Nancy

Faculté de Médecine
BP 20199
9 avenue de la Forêt de Haye
54505 Vandoeuvre les Nancy Cedex

+33 (0)3 72 74 63 26
rntse@inserm.fr